CommercialCoverageMedium impact
08.00.78aw, Self-Administered Drugs and Biologics
Independence Blue Cross·Pharmacy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
IBX updated their policy for self-administered drugs and biologics, affecting coverage and reimbursement positions as well as medical coding requirements. This is a fresh policy change that will impact how practices bill for patient-administered medications and biological products.
Action Required
Before January 1, 2026: Billing team must review updated IBX policy 08.00.78aw for self-administered drugs and biologics at the provided URL to understand new coverage and coding requirements. Update billing software rules and encounter forms based on the specific changes outlined in the full policy. Train staff on new reimbursement positions for patient-administered medications.